These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2846638)

  • 21. Evaluation of cytomegalovirus (CMV) antibody screening tests for blood donors.
    Sererat MN; Schifano JV; Lau P; Beikert E; Bhumbra NA; Nankervis GA
    Am J Clin Pathol; 1986 Oct; 86(4):523-6. PubMed ID: 3020963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rises in antibody to human herpesvirus 6 detected by enzyme immunoassay in transplant recipients with primary cytomegalovirus infection.
    Chou SW; Scott KM
    J Clin Microbiol; 1990 May; 28(5):851-4. PubMed ID: 2161867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [CMV antibody determination with two enzyme immunoassays in each case].
    Albert S; Sibrowski W; Kühnl P; Knödler B; Seidl S; Böhm BO; Doerr HW
    Beitr Infusionsther; 1990; 26():40-2. PubMed ID: 1703884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of latex agglutination and dot immunobinding assay for the detection of cytomegalovirus antibody.
    Wilson MT; Sautter RL; LeBar WD; Mervak TR
    Diagn Microbiol Infect Dis; 1990; 13(4):303-6. PubMed ID: 1963835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Latex agglutination test for cytomegalovirus antibody screening of transplant donors. Important aspects.
    Zbinden R; Decurtins M; Wunderli W
    Diagn Microbiol Infect Dis; 1992 Jul; 15(5):407-9. PubMed ID: 1322809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of four techniques for detection of antibodies to cytomegalovirus.
    Kraat YJ; Hendrix RM; Landini MP; Bruggeman CA
    J Clin Microbiol; 1992 Feb; 30(2):522-4. PubMed ID: 1311337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of cytomegalovirus antibody in platelet concentrates by fluorescence immunoassay and latex agglutination.
    DePalma L; Criss VR; Sullivan MT; Leitman SF; Williams AE; Luban NL
    Transfusion; 1991; 31(3):245-8. PubMed ID: 1848376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches.
    Tischer S; Dieks D; Sukdolak C; Bunse C; Figueiredo C; Immenschuh S; Borchers S; Stripecke R; Maecker-Kolhoff B; Blasczyk R; Eiz-Vesper B
    J Immunol Methods; 2014 Jun; 408():101-13. PubMed ID: 24877879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of viral cultures and serologic tests for cytomegalovirus infection. Rational or random?
    Mangano WE; Gruninger RP
    Am J Clin Pathol; 1996 Aug; 106(2):180-4. PubMed ID: 8712170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of an in-house assay for cytomegalovirus immunoglobulin G (CMV IgG) avidity and relationship of avidity to CMV IgM levels.
    Prince HE; Leber AL
    Clin Diagn Lab Immunol; 2002 Jul; 9(4):824-7. PubMed ID: 12093680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recognition of cytomegalovirus clinical isolate antigens by sera from cytomegalovirus-negative blood donors.
    Rahbar AR; Sundqvist VA; Wirgart BZ; Grillner L; Söderberg-Naucler C
    Transfusion; 2004 Jul; 44(7):1059-66. PubMed ID: 15225248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Should heart-lung transplant donors and recipients be matched according to cytomegalovirus serologic status?
    Novick RJ; Menkis AH; McKenzie FN; Reid KR; Ahmad D
    J Heart Transplant; 1990; 9(6):699-706. PubMed ID: 2177496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is screening for IgG antibody to cytomegalovirus and Epstein-Barr virus infections mandatory in potential renal transplant recipients and donors in Iran?
    Saghafi H; Qorashi M; Heidari A
    Transplant Proc; 2009 Sep; 41(7):2761-3. PubMed ID: 19765428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of cytomegalovirus antibodies in Norwegian kidney-transplant recipients and their living donors. A comparative study of two different methods.
    Skar AG; Hoddevik G
    Acta Pathol Microbiol Immunol Scand B; 1984 Feb; 92(1):1-5. PubMed ID: 6324531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic value of enzyme linked immuno-sorbent assay for cytomegalovirus disease.
    Priya K; Madhavan HN
    J Postgrad Med; 2002; 48(3):176-8; discussion 190. PubMed ID: 12432189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of immunoglobulin G antibodies to cytomegalovirus antigens by antibody capture enzyme-linked immunosorbent assay.
    Nielsen SL; Rønholm E; Sørensen I; Andersen HK
    J Clin Microbiol; 1986 Dec; 24(6):998-1003. PubMed ID: 3023443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic utility of monitoring cytomegalovirus-specific immunity by QuantiFERON-cytomegalovirus assay in kidney transplant recipients.
    Deborska-Materkowska D; Perkowska-Ptasinska A; Sadowska A; Gozdowska J; Ciszek M; Serwanska-Swietek M; Domagala P; Miszewska-Szyszkowska D; Sitarek E; Jozwik A; Kwiatkowski A; Durlik M
    BMC Infect Dis; 2018 Apr; 18(1):179. PubMed ID: 29661141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of cytomegalovirus antibodies by means of CF, ELISA and immunoblotting techniques.
    Jankowski M; Styczyński P
    Arch Immunol Ther Exp (Warsz); 1987; 35(3):313-9. PubMed ID: 2833198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis of cytomegalovirus infection in heart transplant recipients.
    Rice PS; Kudesia G; Price C; Smith GH
    J Clin Pathol; 1992 Jul; 45(7):636-7. PubMed ID: 1325481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of CMV infection by screening for CMV antibodies in renal allograft recipients and their blood and kidney donors.
    Metselaar HJ; Ploeg RJ; Van Loon AM; Weiland HT; Rothbarth PH; Paul LC; Brand A; Schaafsma R; Hendriks GF; Jeekel J
    Scand J Infect Dis; 1988; 20(2):135-9. PubMed ID: 2840730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.